STOCK TITAN

Amicus Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) announced participation in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference, scheduled for September 14, 2022, at 12:20 p.m. E.T. in New York City. The event will be accessible via a live audio webcast on the company’s investor relations website. Amicus Therapeutics focuses on developing innovative therapies for rare metabolic diseases, emphasizing high-quality patient care and a commitment to expanding its pipeline of medicines.

Positive
  • None.
Negative
  • None.

PHILADELPHIA, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference in New York, NY on Wednesday, September 14, 2022 at 12:20 p.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Executive Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G


FAQ

What is Amicus Therapeutics participating in on September 14, 2022?

Amicus Therapeutics will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference.

Where can I access the Amicus Therapeutics conference webcast?

The live audio webcast can be accessed via the investors section of the Amicus Therapeutics corporate website.

What does Amicus Therapeutics focus on?

Amicus Therapeutics specializes in developing innovative medicines for rare metabolic diseases.

What time is Amicus Therapeutics' event at the Morgan Stanley conference?

The event is scheduled for September 14, 2022, at 12:20 p.m. E.T.

What is the stock symbol for Amicus Therapeutics?

Amicus Therapeutics is traded under the stock symbol FOLD.

Amicus Therapeutics, Inc

NASDAQ:FOLD

FOLD Rankings

FOLD Latest News

FOLD Stock Data

2.89B
267.94M
0.74%
105.23%
7.03%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PRINCETON